Mark your Calendars NOW for…
Regional Mitochondrial Medicine 2018: San Diego, CA
Clinical/Medical Sessions: Friday, February 23, 2018
Patient/Family Sessions: Saturday, February 24, 2018
University of California San Diego, Department of Neurosciences
Center for Neural Circuits and Behavior (CNCB), Large Conference Room
9500 Gilman Drive
La Jolla, CA 92093
About the UMDF Regional Symposia
Over the past 15 years, the UMDF has witnessed many changes in educational programming specific to mitochondrial medicine. In 2000, the UMDF hosted its first symposium and at that time, there was only one other entity, Mitochondrial Medicine Society (MMS), offering a conference dedicated solely to mitochondrial medicine in the United States.
The physician audience for the international symposium is typically limited to researchers, and those mitochondrial specialists interested in research, due to the scientific content. Upon review of past attendees at the UMDF international symposium and through strategic planning discussions, the UMDF realized it was missing a very important target audience, the local specialists treating mitochondrial patients. The UMDF added a “Grand Rounds” program in 2008 which brings a mitochondrial specialist to the hospitals to speak to neurologists and geneticists during their regularly scheduled monthly CME programs.
While the Grand Rounds program has been very successful, it is somewhat limited as the hospitals typically only offer one hour time slots. The UMDF Scientific and Medical Advisory Board (SMAB) advised the foundation that the one hour grand rounds sessions were just not sufficient in providing the necessary information to gain a better understanding of managing a patient with mitochondrial disease.
The UMDF is proud to enhance our educational programming through regional symposia and will introduce it in key locations across the United States. The new program will offer a full day CME activity on Friday and a half day of sessions for patients/families on the following Saturday. The UMDF hopes to see this program build in the coming years – not only through our efforts but also by collaborating with other organizations to reach as many clinicians and allied health as possible. Together, we will make a difference in the lives of patients/families struggling with mitochondrial disease.
Clinical Session Schedule (Credit Available)
Friday, February 23, 2018
|7:30 am-8:15 am||Continental Breakfast and Registration Sign-in|
|8:15 a.m-8:30 am||Welcome and Introductions – Richard Haas, MD and UMDF Staff
(Review the GR and the day)
|8:30 am-9:30 am||UCSD Neurosciences Grand Rounds-Mitochondrial DNA Depletion Disorders
Speaker Name: Michio Hirano, MD (1 credit hour/not included in the regional symposium credits noted below)
|9:30 am-10:20 am||Mitochondrial Disease Primer
Speaker Name: Marni Falk, MD
|10:20 am-10:50 am||Break|
|10:50 am-11:40 am||Screening and Evaluation of Mitochondrial Disorders
Speaker Name: Richard Haas, MB BChir
|11:40 am – 12:30pm||Current and Potential Treatments and Therapies
Speaker Name: Bruce H. Cohen, MD
|1:30 pm – 2:00 pm||MMS and Practice Patterns and the UMDF Roadmap
Speakers: Bruce Cohen, MD and Richard Haas, MB Bchir
|2:00 pm – 2:45 pm||Patient Care Standards for Mitochondrial Disease
Speaker Name: Annette Feigenbaum MB ChB FRCP DABMG
|2:45 pm – 3:15 pm||Break|
|3:15 pm – 4:00 pm||The Promise of Antipurinergic Therapy
Speaker Name: Robert Naviaux MD PhD
|4:00 pm – 4:45 pm||Metabolomics – Next Generation Diagnostics
Speaker Name: Bruce Barshop MD PhD
|4:45 pm – 5:15 pm||Rapid Whole Genome Sequencing (rWGS) (TENTATIVE)
Speaker Name: David Dimmock, MD
|5:15 pm – 5:30 pm||Questions and Answers
Speaker Panel: Hirano, Falk, Haas, Cohen, Feigenbaum, Naviaux, Barshop
Family Session Schedule (Credit Not Available)
Saturday, February 24, 2018
|8:00 am-9:00 am||Continental Breakfast, Registration Sign-in, Networking time, etc.|
|9:00 am-9:15 am||Welcome and Introductions – Richard Haas, MD|
|9:15 am-10:00 am||Mitochondrial Disease: What is It and What to Expect?
Speaker Name: Marni Falk, MD
|10:00 am-10:30 am||Break|
|10:30 am-11:15 am||Screening and Evaluation
Speaker Name: Michio Hirano, MD
|11:30 am – 1:30 pm||UMDF Roadmap Update with Box Lunch with Question and Answers – All speakers noted above and local mitochondrial specialists|
|1:30 pm – 2:15 pm||Current & Potential Therapies in the Treatment of Mitochondrial Diseases
Speaker Name: Bruce H. Cohen, MD
|2:15 pm – 3:00 pm||UMDF Closing and Networking Time|
2018 Course Description
The United Mitochondrial Disease Foundation and University of California San Diego School of Medicine have joined efforts to sponsor and organize a CME-accredited regional symposium. Mitochondrial diseases are more common than previously recognized and mitochondrial pathophysiology is now a recognized part of many disease processes, including heart disease, cancer, AIDS and diabetes. There have been significant advances in the molecular genetics, proteomics, epidemiology and clinical aspects of mitochondrial pathophysiology. This conference is directed toward the clinician interested in all aspects of mitochondrial medicine. The content of this educational program was determined by rigorous assessment of educational needs and includes surveys, program feedback, expert faculty assessment, literature review, medical practice, and new medical knowledge. The format will include didactic lectures from invited experts. There will be ample time for professional discussion both in and out of the meeting room throughout the meeting. This is a one day meeting aimed at those with clinical interests.
Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, and Residents/Fellows/Students.
At the end of the program, attendees will have an in-depth understanding of the following areas:
- Explain the basic science of mitochondrial function and how dysfunction can lead to mitochondrial disease.
- Illustrate the symptoms and recognize the “red-flag” symptoms of mitochondrial disease.
- Demonstrate how to begin a mitochondrial evaluations.
- Explain the issue of certainty of diagnosis.
- Explain the concepts of primary and secondary mitochondrial disorders.
- Summarize the goals of therapy and to present the current treatments available based on the most recent studies presented in the peer-reviewed medical literature.
- Explain the available diagnostic testing, based on mitochondrial function, and to review new and expanding opportunities including next gen sequencing.
- Recognize the link between mitochondrial function and dysfunction to common disorders such as autism.
- Recognize the role of exercise testing in diagnosis and management of patients with mitochondrial disorder.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, San Diego School of Medicine and the United Mitochondrial Disease Foundation. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of California, San Diego School of Medicine designates this meeting for a maximum of 5.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.
Cultural and Linguistic Competency:
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UCSD CME website at http://cme.ucsd.edu
2018 Regional Symposium Faculty and Planning Committee
- Richard Haas, MB, BChir, MRCP, Course Chair, UCSD, San Diego, CA
- Bruce Barshop, MD, PhD, UCSD, San Diego, CA
- Bruce H. Cohen, MD, Akron Children’s Hospital, Akron, OH
- Marni Falk, MD, Children’s Hospital of Philadelphia, PA
- Annette Feigenbaum, MD, UCSD, San Diego, CA
- Lilly Lee, Research Assistant, UCSD, San Diego, CA
- Michio Hirano, MD, Columbia University, New York, NY
- Robert K. Naviaux, MD, PhD, University California San Diego, CA
- Kara Strittmatter, CMM, MA, United Mitochondrial Disease Foundation, Pittsburgh, PA
Support & Exhibit
Here are some of the reasons you can’t miss this support and exhibiting opportunity!
- The exhibit location promotes one-on-one interaction among attendees and exhibitors — your company can have the attendees’ undivided attention.
- Attendees are decision-makers and influencers for the products and services utilized by their facilities and in their practices.
- Family attendees pose a valuable resource for many companies since they, too, are decision-makers and influencers.
- Excellent networking opportunities during all breaks and lunch.
Space assignments are made on a first come, first served basis and space is limited.
To reserve space and to get pricing information, please contact:
United Mitochondrial Disease Foundation
8085 Saltsburg Road, Suite 201
Pittsburgh, PA 15239